Livongo Health→Teladoc
Acquisition · Stock-for-stock merger · TDOC · announced Aug 5, 2020
Announced
Aug 5, 2020
Closed
Oct 30, 2020
Economics
Stock-for-stock merger()
Pre-deal · pre-deal mark: 2020-07, month precision · NASDAQ market capitalization, July 2020 (pre-merger announcement)
Close-date disclosed consideration (~$13.9B). Teladoc 8-K (Aug 5, 2020) valued the exchange at $18.5B on Teladoc's Aug 4, 2020 close.
Target
Livongo Health
General Wellness · Consumer wellness
HQ Mountain View, CA · Founded 2008
Chronic condition management (diabetes, hypertension); large female user base; included for the Teladoc merger reference
- SEC 8-K filing (Teladoc, Aug 5, 2020 announcement; Oct 30, 2020 close)
- Teladoc Health investor relations press release (Aug 5, 2020)
- Crunchbase - crunchbase.com/organization/livongo-health
Acquirer
Teladoc Health (TDOC)
General Wellness
HQ Purchase, NY
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Combined chronic care management with virtual primary care to create comprehensive digital health platform
Evidence ladder
Primary (regulatory / filing)
Teladoc Health 8-K filing, SEC EDGAR (Aug 5, 2020)
SEC EDGAR filings (ticker locator)Secondary (press / IR)
Teladoc Health investor relations press release (Aug 5, 2020)
Primary (regulatory / filing)
SEC EDGAR 8-K https://www.sec.gov/Archives/edgar/data/1477449/000110465920090575/tm2026658d1_8k.htm
Open source
Limitations
- Close-date disclosed consideration (~$13.9B). Teladoc 8-K (Aug 5, 2020) valued the exchange at $18.5B on Teladoc's Aug 4, 2020 close.
- Pre-deal valuation sourced from: NASDAQ market capitalization, July 2020 (pre-merger announcement). Pre-deal market-cap and funding citations do not corroborate the acquisition.
Same-sector adjacency — not valuation peers
These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.
| Target | Acquirer | Announced | Value | Vs this deal |
|---|---|---|---|---|
| Nurx | Ro | Dec 15, 2021 | ||
| Apostrophe | Hims & Hers Health | Jun 24, 2021 |
Other verified deals by Teladoc Health
Acquirer program history not already listed as a valuation peer or adjacency row.
| Target | Acquirer | Announced | Value | Sector |
|---|---|---|---|---|
| Kindbody | Teladoc | Mar 15, 2023 | Undisclosed | Fertility |
| Maven Clinic | Teladoc | Aug 10, 2022 | Undisclosed | Fertility |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Livongo Health (General Wellness). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 3 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.